| Code | Description | Claims | Beneficiaries | Total Paid |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
30,366 |
26,788 |
$3.87M |
| 96361 |
Intravenous infusion, hydration; each additional hour |
12,710 |
9,865 |
$3.65M |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
32,525 |
26,651 |
$3.47M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
28,585 |
26,072 |
$3.33M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
17,722 |
15,464 |
$2.47M |
| 70450 |
Computed tomography, head or brain; without contrast material |
4,644 |
3,712 |
$1.12M |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
9,241 |
2,508 |
$716K |
| 11043 |
|
2,238 |
1,225 |
$671K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
3,011 |
2,282 |
$658K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
4,724 |
3,869 |
$567K |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
678 |
570 |
$470K |
| G0378 |
Hospital observation service, per hour |
6,742 |
2,461 |
$440K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
3,692 |
1,607 |
$406K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
3,834 |
3,338 |
$375K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
3,508 |
1,752 |
$355K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
1,211 |
937 |
$287K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
696 |
579 |
$286K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
1,425 |
1,073 |
$278K |
| 59025 |
Fetal non-stress test |
1,758 |
1,000 |
$272K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
1,052 |
878 |
$253K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
5,520 |
4,966 |
$226K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
2,197 |
1,606 |
$221K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
29,153 |
23,027 |
$204K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
1,091 |
519 |
$190K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
1,204 |
930 |
$178K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
665 |
537 |
$171K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
5,904 |
1,769 |
$158K |
| 90791 |
Psychiatric diagnostic evaluation |
574 |
447 |
$117K |
| 70496 |
|
475 |
369 |
$113K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
4,431 |
1,379 |
$97K |
| 80053 |
Comprehensive metabolic panel |
12,952 |
10,631 |
$87K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
968 |
788 |
$84K |
| C8929 |
Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography |
402 |
345 |
$83K |
| 95811 |
|
116 |
101 |
$81K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
714 |
591 |
$76K |
| 76830 |
Ultrasound, transvaginal |
742 |
605 |
$72K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
4,151 |
3,527 |
$69K |
| 76642 |
|
546 |
441 |
$65K |
| 93017 |
|
776 |
651 |
$63K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
1,311 |
1,098 |
$61K |
| 93970 |
|
468 |
382 |
$60K |
| 84484 |
|
17,112 |
9,713 |
$56K |
| 93971 |
|
718 |
595 |
$48K |
| 97161 |
|
1,142 |
945 |
$48K |
| 72131 |
|
722 |
580 |
$41K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
213 |
207 |
$40K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
274 |
238 |
$39K |
| 71046 |
Radiologic examination, chest; 2 views |
1,801 |
1,594 |
$39K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
1,756 |
735 |
$38K |
| 71250 |
|
452 |
384 |
$35K |
| 71045 |
Radiologic examination, chest; single view |
18,522 |
15,915 |
$27K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
191 |
156 |
$25K |
| 97116 |
|
1,251 |
539 |
$25K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
2,177 |
1,684 |
$24K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
20,281 |
16,760 |
$24K |
| 80320 |
|
2,329 |
1,831 |
$23K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
98 |
81 |
$22K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
42,847 |
35,962 |
$21K |
| 87400 |
|
1,054 |
531 |
$21K |
| 97162 |
|
711 |
543 |
$21K |
| 93458 |
|
16 |
12 |
$20K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
54 |
40 |
$20K |
| 95819 |
|
128 |
107 |
$18K |
| 86850 |
|
1,134 |
826 |
$18K |
| 36415 |
Collection of venous blood by venipuncture |
16,208 |
12,573 |
$18K |
| G0279 |
Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) |
493 |
435 |
$15K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
1,299 |
1,104 |
$15K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
240 |
233 |
$15K |
| 70486 |
|
540 |
427 |
$14K |
| 97535 |
Self-care/home management training, each 15 minutes |
536 |
334 |
$14K |
| 90715 |
|
940 |
743 |
$14K |
| 74018 |
|
414 |
332 |
$13K |
| 76536 |
|
101 |
90 |
$13K |
| 88341 |
|
477 |
202 |
$13K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
12,542 |
9,369 |
$12K |
| 86900 |
|
1,246 |
938 |
$12K |
| 97597 |
|
109 |
66 |
$12K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
988 |
826 |
$11K |
| 72100 |
|
339 |
282 |
$10K |
| 0002A |
|
312 |
302 |
$10K |
| 78815 |
Positron emission tomography (PET) for limited area imaging |
15 |
13 |
$10K |
| 0001A |
|
338 |
325 |
$10K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
17,763 |
15,187 |
$8K |
| 97166 |
|
280 |
205 |
$8K |
| 73560 |
|
613 |
456 |
$8K |
| 77065 |
Tomosynthesis, mammo |
283 |
221 |
$8K |
| J3490 |
Unclassified drugs |
4,387 |
2,338 |
$8K |
| 73030 |
|
814 |
586 |
$8K |
| 85027 |
|
2,908 |
1,482 |
$8K |
| 72128 |
|
337 |
266 |
$8K |
| 81001 |
|
19,874 |
17,664 |
$7K |
| 87070 |
|
1,566 |
1,226 |
$7K |
| 74178 |
|
64 |
40 |
$7K |
| 12001 |
|
54 |
39 |
$7K |
| 96376 |
|
3,028 |
1,324 |
$6K |
| 77066 |
Tomosynthesis, mammo |
350 |
303 |
$6K |
| 70491 |
|
19 |
12 |
$6K |
| 73610 |
|
657 |
538 |
$6K |
| 73630 |
|
894 |
731 |
$5K |
| 96367 |
|
164 |
104 |
$5K |
| 73130 |
|
759 |
600 |
$5K |
| 70498 |
|
464 |
364 |
$5K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
12,915 |
10,031 |
$5K |
| 81025 |
|
10,811 |
9,226 |
$4K |
| 80076 |
|
445 |
413 |
$4K |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
269 |
242 |
$4K |
| 85610 |
|
3,706 |
2,747 |
$4K |
| 97113 |
|
97 |
29 |
$4K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
16 |
12 |
$3K |
| 73562 |
|
328 |
255 |
$3K |
| 95886 |
|
14 |
13 |
$3K |
| 73502 |
|
300 |
226 |
$3K |
| 82565 |
|
415 |
348 |
$3K |
| 76775 |
|
40 |
36 |
$3K |
| C1889 |
Implantable/insertable device, not otherwise classified |
40 |
27 |
$3K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
4,012 |
2,662 |
$3K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
4,430 |
3,913 |
$3K |
| 82248 |
|
7,060 |
5,548 |
$3K |
| 80061 |
Lipid panel |
505 |
373 |
$3K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
659 |
553 |
$3K |
| 80055 |
|
118 |
108 |
$3K |
| 83735 |
|
2,359 |
1,616 |
$3K |
| 87040 |
|
1,723 |
706 |
$3K |
| 12011 |
|
14 |
13 |
$2K |
| 71271 |
|
14 |
13 |
$2K |
| 84443 |
Thyroid stimulating hormone (TSH) |
733 |
540 |
$2K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
2,460 |
1,215 |
$2K |
| H1002 |
Prenatal care, at risk enhanced service; care coordination |
546 |
491 |
$2K |
| G0475 |
Hiv antigen/antibody, combination assay, screening |
122 |
111 |
$2K |
| 73110 |
|
311 |
260 |
$2K |
| 88142 |
|
128 |
115 |
$2K |
| 86901 |
|
1,246 |
938 |
$2K |
| 85730 |
|
2,761 |
2,008 |
$2K |
| 84439 |
|
427 |
323 |
$2K |
| J2800 |
Injection, methocarbamol, up to 10 ml |
516 |
343 |
$1K |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
2,810 |
1,139 |
$1K |
| 83690 |
|
8,008 |
6,643 |
$1K |
| 97163 |
|
81 |
59 |
$1K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
10,952 |
8,928 |
$1K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
985 |
818 |
$1K |
| 73590 |
|
338 |
242 |
$1K |
| 83880 |
|
1,277 |
991 |
$1K |
| 83605 |
|
1,795 |
1,124 |
$1K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
987 |
777 |
$1K |
| 90686 |
|
33 |
31 |
$1K |
| 72141 |
|
17 |
12 |
$1K |
| 82550 |
|
711 |
445 |
$991.89 |
| 82950 |
|
133 |
128 |
$990.74 |
| 76937 |
|
16 |
12 |
$978.57 |
| 85379 |
|
1,390 |
1,106 |
$895.48 |
| 87430 |
|
1,483 |
1,274 |
$866.14 |
| 72040 |
|
22 |
14 |
$861.95 |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
12 |
12 |
$814.34 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
7,914 |
5,088 |
$813.17 |
| 97167 |
|
87 |
53 |
$805.86 |
| 82803 |
|
1,201 |
900 |
$801.76 |
| 81000 |
|
2,759 |
2,225 |
$782.67 |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
755 |
681 |
$748.51 |
| G0476 |
Infectious agent detection by nucleic acid (dna or rna); human papillomavirus (hpv), high-risk types (e.g., 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) for cervical cancer screening, must be performed in addition to pap test |
30 |
26 |
$739.91 |
| 87088 |
|
2,378 |
2,006 |
$724.05 |
| 84100 |
|
448 |
225 |
$719.14 |
| 84702 |
|
698 |
548 |
$715.66 |
| 81003 |
|
2,077 |
1,613 |
$684.95 |
| 87147 |
|
524 |
361 |
$681.35 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
4,865 |
3,194 |
$651.79 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
11,731 |
8,597 |
$640.73 |
| J0500 |
Injection, dicyclomine hcl, up to 20 mg |
48 |
39 |
$640.24 |
| J2543 |
Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) |
177 |
64 |
$565.42 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,663 |
844 |
$542.68 |
| 85014 |
|
379 |
189 |
$524.34 |
| 72110 |
|
14 |
13 |
$493.39 |
| 87077 |
|
1,218 |
796 |
$469.64 |
| J1050 |
Injection, medroxyprogesterone acetate, 1 mg |
180 |
156 |
$451.72 |
| 72170 |
|
440 |
329 |
$404.11 |
| C9113 |
Injection, pantoprazole sodium, per vial |
441 |
145 |
$389.82 |
| J1815 |
Injection, insulin, per 5 units |
586 |
175 |
$358.09 |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
51 |
26 |
$298.26 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
1,431 |
818 |
$296.95 |
| 85018 |
|
384 |
189 |
$289.18 |
| 87186 |
|
1,186 |
804 |
$282.10 |
| J3535 |
Drug administered through a metered dose inhaler |
318 |
81 |
$256.09 |
| 73552 |
|
84 |
65 |
$255.31 |
| J0360 |
Injection, hydralazine hcl, up to 20 mg |
246 |
139 |
$247.96 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
3,257 |
2,049 |
$236.39 |
| 80069 |
|
21 |
12 |
$217.84 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
825 |
601 |
$181.07 |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
158 |
132 |
$174.11 |
| 80143 |
|
380 |
275 |
$172.05 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
1,961 |
1,189 |
$167.27 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
35 |
16 |
$150.96 |
| J1644 |
Injection, heparin sodium, per 1000 units |
1,492 |
520 |
$147.52 |
| 82010 |
|
204 |
132 |
$145.70 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
230 |
153 |
$137.14 |
| 84703 |
|
137 |
117 |
$136.92 |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
984 |
634 |
$128.68 |
| 90656 |
|
12 |
12 |
$123.67 |
| 88342 |
|
621 |
380 |
$117.86 |
| 82140 |
|
117 |
71 |
$112.94 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
163 |
126 |
$107.96 |
| J3370 |
Injection, vancomycin hcl, 500 mg |
185 |
82 |
$107.45 |
| J3360 |
Injection, diazepam, up to 5 mg |
121 |
85 |
$102.14 |
| J2060 |
Injection, lorazepam, 2 mg |
834 |
526 |
$99.57 |
| G0008 |
Administration of influenza virus vaccine |
12 |
12 |
$76.59 |
| 82330 |
|
49 |
26 |
$72.71 |
| J3480 |
Injection, potassium chloride, per 2 meq |
375 |
153 |
$71.79 |
| 87210 |
|
121 |
102 |
$71.02 |
| J3372 |
Injection, vancomycin hcl (xellia), not therapeutically equivalent to j3370, 500 mg |
117 |
70 |
$70.17 |
| 73080 |
|
13 |
12 |
$67.89 |
| J2704 |
Injection, propofol, 10 mg |
3,015 |
2,190 |
$59.75 |
| 80179 |
|
335 |
253 |
$57.33 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
794 |
469 |
$55.31 |
| 86140 |
|
30 |
25 |
$52.80 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
1,399 |
956 |
$50.96 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
3,169 |
2,019 |
$45.00 |
| 87075 |
|
53 |
42 |
$43.73 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
1,286 |
918 |
$42.49 |
| 73090 |
|
150 |
98 |
$37.77 |
| J1790 |
Injection, droperidol, up to 5 mg |
324 |
223 |
$32.33 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
3,300 |
2,219 |
$31.50 |
| 84132 |
|
39 |
25 |
$30.52 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
92 |
58 |
$23.95 |
| J2795 |
Injection, ropivacaine hydrochloride, 1 mg |
122 |
89 |
$22.79 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
105 |
58 |
$16.52 |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
40 |
26 |
$15.81 |
| 85652 |
|
69 |
54 |
$13.83 |
| 87205 |
|
24 |
12 |
$12.04 |
| 87176 |
|
16 |
13 |
$9.43 |
| J2360 |
Injection, orphenadrine citrate, up to 60 mg |
118 |
78 |
$9.30 |
| J2175 |
Injection, meperidine hydrochloride, per 100 mg |
60 |
40 |
$7.60 |
| J8499 |
Prescription drug, oral, non chemotherapeutic, nos |
69 |
38 |
$7.52 |
| 91300 |
|
590 |
548 |
$5.13 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
217 |
155 |
$4.79 |
| J1596 |
Injection, glycopyrrolate, 0.1 mg |
212 |
170 |
$2.54 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
154 |
86 |
$2.36 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
768 |
477 |
$2.20 |
| J1940 |
Injection, furosemide, up to 20 mg |
63 |
33 |
$2.01 |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
24 |
12 |
$1.95 |
| J7050 |
Infusion, normal saline solution, 250 cc |
651 |
367 |
$0.48 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
5,604 |
4,261 |
$0.00 |
| Q9956 |
Injection, octafluoropropane microspheres, per ml |
175 |
150 |
$0.00 |
| H1000 |
Prenatal care, at-risk assessment |
109 |
101 |
$0.00 |
| 94060 |
|
16 |
14 |
$0.00 |
| Q9966 |
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
234 |
177 |
$0.00 |
| A9575 |
Injection, gadoterate meglumine, 0.1 ml |
893 |
741 |
$0.00 |
| 00840 |
|
32 |
26 |
$0.00 |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
72 |
38 |
$0.00 |
| 94726 |
|
16 |
14 |
$0.00 |
| 94729 |
|
16 |
14 |
$0.00 |
| A9552 |
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries |
14 |
12 |
$0.00 |
| 73070 |
|
13 |
12 |
$0.00 |
| 99078 |
|
29 |
24 |
$0.00 |
| 00731 |
|
14 |
13 |
$0.00 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
14 |
13 |
$0.00 |
| 88304 |
|
215 |
134 |
$0.00 |
| J2785 |
Injection, regadenoson, 0.1 mg |
557 |
464 |
$0.00 |
| J2371 |
Injection, phenylephrine hydrochloride, 20 micrograms |
30 |
16 |
$0.00 |
| Q9969 |
Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study dose |
789 |
636 |
$0.00 |
| A9270 |
Non-covered item or service |
124 |
76 |
$0.00 |
| 94761 |
|
15 |
14 |
$0.00 |
| 82607 |
|
17 |
14 |
$0.00 |
| C1769 |
Guide wire |
280 |
204 |
$0.00 |
| H1001 |
Prenatal care, at-risk enhanced service; antepartum management |
45 |
27 |
$0.00 |
| 82746 |
|
15 |
12 |
$0.00 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
39 |
39 |
$0.00 |
| 81015 |
|
12 |
12 |
$0.00 |